Self-Reported Prescription Opioid Use During Pregnancy
The CDC analyzed prescription opioid use during pregnancy via a self-reported survey.
Pain Management Information Center
Spotlight on Fibromyalgia: Updates on Diagnosis and Clinical Management
Fibromyalgia is a chronic pain condition characterized by widespread musculoskeletal pain, sleep disturbance, fatigue.
ACP/AAFP Publish Guideline on Managing Acute Pain From Musculoskeletal Injuries
This guideline provides recommendations for managing acute pain resulting from non–low back, musculoskeletal injuries in adults.
Best Practices for Chronic Pain Fellows During the COVID-19 Pandemic
Recommendations for addressing mental health among pain management fellows during the COVID-19 pandemic.
FDA Requires Labeling Changes for Opioids to Include Information About Naloxone
The FDA has announced that it is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder to include new recommendations about naloxone to the prescribing information.
Do Opioids Have a Role in the Management of Knee and Hip Osteoarthritis?
Researchers assessed pain relief and functional improvement in patients receiving opioids for knee or hip osteoarthritis.
Clinical Outcomes Associated With Ibuprofen Use During COVID-19
A team of investigators assessed clinical outcomes among patients with COVID-19 receiving ibuprofen for fever reduction.
Geriatric Patients May Underreport Pain Severity Compared With Younger Patients
Geriatric patients reported lower pain scores for rib fracture than younger patients, contributing to the ideology that geriatric patients may underreport pain severity.
The Emerging Role of Nurse Practitioners in Physical Medicine and Rehabilitation
Nurse Practitioners can provide efficacious care to people with disabilities, resulting in cost savings, improved outcomes, and high value.
Contextual Effect Enhances Management of Knee Osteoarthritis
Researchers aimed to clarify the role of contextual effect in widely used nonpharmacologic, nonsurgical treatments for knee osteoarthritis by conducting a literature review of knee osteoarthritis trials.
Galcanezumab Linked to Improved Work Productivity in Patients With Migraine
Galcanezumab was found to significantly improve work productivity and reduce interictal burden in patients with treatment-resistant migraine, according to results from the phase 3 CONQUER study.
Positive Outcomes Reported With Novel Intranasal DHE for Migraine
Positive results were announced from the phase 3 STOP-301 study evaluating INP104 (intranasal dihydroergotamine mesylate; Impel NeuroPharma) for the treatment of acute migraine in adults.
Some Patients With Early-Stage Breast Cancer Found to Be at Risk of Prolonged Opioid Use After Surgery
Patients with early-stage breast cancer who undergo mastectomy with or without reconstruction are at risk of prolonged opioid use.
Prescription Drug Monitoring Programs May Prevent Patients With Cancer From Receiving Pain Management Therapy
Prescription drug monitoring programs that aim to prevent opioid misuse may be affecting patients with cancer who need pain management.
Repetitive Multiple Cranial Nerve Blocks Offer Effective Prevention for Chronic Migraine
Repetitive multiple cranial nerve blocks may offer a clinically meaningful benefit as a preventative measure in patients with chronic migraine.
Prophylactic Manual Acupuncture Reduces Migraine Days
Undergoing 20 sessions of manual acupuncture is superior to sham acupuncture and usual care for prophylactic treatment in migraine.
FDA Clears Hand-Held Vagus Nerve Stimulator for Migraine Prevention
The FDA has approved an expanded indication for the gammaCore device to include prevention of migraine.
Network Analysis Supports Targeting Patients’ Strengths to Treat Chronic Pain
Depression is twice as common in patients with chronic pain compared to health subjects, and pain intensity, frequency, and number of locations are linked to depression and anxiety.
DEA: 2020 Drugs of Abuse Resource Guide Now Available
The guide includes information on a drug’s origin, common street names, how it is abused, what effect it has on the mind and body, what the overdose effects are, and what its legal status is in the US.
AMA Releases Recommendations for Opioid Use Disorder, Pain During COVID-19
The AMA called for alterations for insurers, including terminating cost-sharing and prior authorization for chronic pain and OUD medications and removing restrictions on Medicaid preferred drug lists.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Pain Management Information Center
